-
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension
Protocol 1698-301-007, Allergan (North America), Irvine CA, 2019 – Present
-
A Phase 1b Study of TAK-659 in Combination With Venetoclax for Adult Patients With Previously Treated Non-Hodgkin Lymphoma
Protocol C34008, Millennium Pharmaceuticals Inc, Cambridge, MA, 2019 – Present
-
A Prospective Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Posterior Chamber Silicone Intraocular Lens for Primary Implantation in the Capsular Bag of the Eye for Visual Correction of Aphakia Secondary to Removal of a Cataractous Lens in Adult Patients With or Without Presbyopia
Principal Investigator
Protocol SC9-0015, CORD, LLC, Alisa Viejo, CA, 2018 – Present
-
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 to Treat Chronic Non-healing Foot Ulcers in Diabetic Patients with Concomitant Peripheral Arterial Disease (PAD)
Protocol VMNHU-003, Helixmith Co. LTD, 2018 – Present
-
Evaluation of Bimatoprost 0.01% and Bimatoprost 0.03% in Patients with Glaucoma or Ocular Hypertension
Principal Investigator
Protocol 192024-081, Allergan (North America), Irvine, CA, 2013-Present
-
Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 3 – MEK162 for Patients With RAS/RAF/MEK Activated Tumors
Protocol CMEK 162AUS11, Novartis Pharmaceuticals, USA, 2013 -Present
-
Ophthalmic AGN-195263 for the Treatment of Meibomian Gland Dysfunction
Principal Investigator
Protocol 195263-006, Allergan, 2525 Dupont Drive, Irvine, CA 92612, 2012-2015
-
A Prospective Randomized Controlled Multi-Center Clinical Study to Evaluate the Safety and Effectiveness of the Light Adjustable Lens(LAL) in Subjects with Pre-existing Corneal Astigmatism.
Protocol CSP-002-03, Calhoun Vision Inc., 133 N. Altadena Drive, Suite 302, Pasadena, CA 91107, 2011 -2012
-
A 12-Month Open-Label Multicenter Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects with Chronic Sinusitis With or Without Nasal Polyps
Protocol OPN-FLU-CS-3203, OptiNose US, Inc, 2012
-
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Principal Investigator
Protocol number: AI-001, Dr. Schmidt Intraocularlinsen GmbH, Westerwaldstrasse 11-13, D-53757 St., Augustin D-53757, Germany, 2011
-
A Prospective, Multicenter Post-Approval Study (PAS) of VisionCare’s Implantable Miniature Telescope (by Dr. Isaac Lipchitz) in Patients with Bilateral Severe to Profound Central Vision Impairment Associated with End-stage Age-related Macular Degeneration.
Protocol IMT-PAS-01, VisionCare Ophthalmic technologies, Inc., 14395 Saratoga Ave., Suite 150, Saratoga, California 95070, 2011 –
A Multicenter, Randomized, Double-masked, Dose-ranging, Phase 2 Study to Evaluate the Efficacy and Safety of IBI-10090 in Patients Undergoing Cataract Surgery Protocol No. IBI C0901, Icon Bioscience, Inc., 1253 Reamwood Avenue, Sunnyvale, California, 94089, 2009 -2012
-
Clinical Evaluation of the I-ZIP® Adherent Ocular Bandage as a Protective Ocular Bandage in Subjects Undergoing Clear Corneal Cataract Surgery with IOL Implantation: A Pivotal Study Protocol: ITX-08-002, I-Therapeutix, Inc., 204 Second Avenue, Waltham, MA 02451, 2008 – 2009
Moxifloxacin AF for Bacterial Conjunctivitis, An Evaluation of the Safety and Efficacy of Moxifloxacin AF Ophthalmic Solution 0.5% for the Treatment of Bacterial Conjunctivitis in the USA
Protocol: C-07-40, Alcon Research, Ltd., 6201 South Freeway,
Fort Worth, Texas 76134-2099, 2008 – 2009
-
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter, Two-Year Study to Evaluate the Ocular Safety of Once-Daily, Fluticasone Furoate Nasal Spray 110mcgin Adults and Adolescents 12 Years of Age and Older with Perennial Allergic Rhinitis
Clinical Study Identifier: FFR110537, GlaxoSmithKline, Research Triangle Park, NC 27709-3398, USA, 2008 -2009
-
A Phase 2b Multicenter, Randomized, Double-Masked Study of the Safety and Efficacy of Difluprednate 0.05% Ophthalmic Emulsion Compared to Prednisolone Acetate 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis
Clinical Trial Protocol: ST-601A-001, Sirion Therapeutics, Inc., San Diego, CA, 2007 –2008
-
Efficacy and Safety of Bromfenac Ophthalmic Solution 0.18% QD vs. Xibrom™ (Bromfenac Ophthalmic Solution) 0.09% QD for Treatment of Ocular Inflammation, Pain, and Photophobia Associated with Cataract Surgery
Protocol CL-S&E-0802071-P, Ista Pharmaceuticals, Irvine, California, 2007-2008
-
A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Synchrony Dual Optic Intraocular Lens in Patients Undergoing Cataract Extraction
Protocol SYNC-601-IOL, Visiogen, Inc., Irvine, CA, 2005-2012
-
Beta Test for Visante OCT [Anterior Chamber OCT (AC OCT)]
Protocol AC-OCT-2005-02, Carl Zeiss Meditec, Inc., Dublin, CA, 2005 – 2006.
-
Clinical Evaluation of the Tecnis Multifocal Intraocular Lens, Model ZM9000
Protocol DIOL-105-TCNS, Advanced Medical Optics, Inc., Santa Ana CA, 2004 – 2009
-
MEL80 Mixed Astigmatism LASIK Study
Protocol MEL80-2006-2, Carl Zeiss Meditec, Inc, Dublin CA, 2007 – 2009
-
MEL80 High Myopia LASIK Study
Protocol MEL80-2006-1, Carl Zeiss Meditec, Inc, Dublin CA, 2006 – 2008
-
MEL80 Myopia and Hyperopia LASIK
Protocol MEL80-2004, Carl Zeiss Meditec, Inc, Dublin CA, 2004 – 2008
-
EyepassÆ Bi-directional Glaucoma Implant
Protocol BDG 302.01, GMP Vision Solutions, Inc, Ft. Lauderdale FL, 2004 – 2005
-
Rayner Foldable Hydrophilic Acrylic Copolymer IOL
Protocol CenterFlex™ 03EU-USA, Rayner Intraocular Lenses, Ltd., Pasadena CA, 23 September 2003 – 2005
-
AVS Foldable IOL
Protocol AVS-5383, Santen Inc. / Advanced Vision Science, Napa CA, 2002 – 2005
-
Implantable Miniaturized Telescope (IMT™)
Protocol IMT-002 CA4001, VisionCare Ophthalmic Technologies, Inc., Saratoga CA, 2002 – 2005
Phakic Refractive Lens (PRL) for the Treatment of Myopia
Protocol PRL-98-005, version number 10.0, CIBA Vision, Duluth GA, 2001 – 2003
-
Photon Laser Phacoemulsification System
Paradigm Medical Industries, Salt Lake City UT, 2000-2002
-
Phacolase Er: YAG Laser for Cataract Extraction
Asclepion-Meditec (Carl Zeiss Meditec), Jena Germany, 2000-2002
-
crystalens Accommodating IOL
Protocol ARL-55, C&C Vision, Aliso Viejo CA, 2000-2003
-
Morcher endocapsular tension ring
-
Sunrise Technology holmium YAG laser for hyperopia
-
Rapidly Polymerized Collagen Gel as a Smoothing Agent in
Excimer Laser Photoablation
Devore DP, Scott JB, Nordquist RE, Hoffman RS, Eiferman RA
Suburban Hospital – Louisville, Kentucky, 1993.
-
Conservative Management of Ciliary Body Melanomas
Hoffman RS, Haik BG, Smith ME
Department of Ophthalmology
Tulane University School of Medicine, 1992.
-
Investigation of the Microdehiscence in Penetrating Keratoplasty
Hoffman RS, Friedlander MH, Karcioglu ZA, Buzard KA
Department of Ophthalmology
Tulane University School of Medicine, 1991.
-
The Effects of Zinc on Corneoscleral Wound Healing
Hoffman RS, Karcioglu ZA
Department of Ophthalmology
Tulane University School of Medicine, 1990.
-
The Effects of Zinc on Corneal Epithelium Healing
Hoffman RS, Karcioglu ZA
Department of Ophthalmology
Tulane University School of Medicine, 1986.
-
Lecithin as a Cell-to Cell Mediator of Development in the Chick Erythroblast
Hoffman RS
Department of Biology
Haverford College, 1983.
-
A Comparative Analysis of Pyruvate Lyases
Meloche P, Hoffman RS
Papanicolaou Cancer Research Institute of Miami, 1979.